Literature DB >> 24257756

Stress-induced phosphorylation of Thr486 in c-Myb by p38 mitogen-activated protein kinases attenuates conjugation of SUMO-2/3.

Juraj Bies1, Marek Sramko, Linda Wolff.   

Abstract

c-Myb plays an essential role in regulation of properly balanced hematopoiesis through transcriptional regulation of genes directly controlling cellular processes such as proliferation, differentiation, and apoptosis. The transcriptional activity and protein levels of c-Myb are strictly controlled through post-translational modifications such as phosphorylation, acetylation, ubiquitination, and SUMOylation. Conjugation of small ubiquitin-like modifier (SUMO) proteins has been shown to suppress the transcriptional activity of c-Myb. SUMO-1 modifies c-Myb under physiological conditions, whereas SUMO-2/3 conjugation was reported in cells under stress. Because stress also activates several cellular protein kinases, we investigated whether phosphorylation of c-Myb changes in stressed cells and whether a mutual interplay exists between phosphorylation and SUMOylation of c-Myb. Here we show that several types of environmental stress induce a rapid change in c-Myb phosphorylation. Interestingly, the phosphorylation of Thr(486), located in close proximity to SUMOylation site Lys(499) of c-Myb, is detected preferentially in nonSUMOylated protein and has a negative effect on stress-induced SUMOylation of c-Myb. Stress-activated p38 MAPKs phosphorylate Thr(486) in c-Myb, attenuate its SUMOylation, and increase its proteolytic turnover. Stressed cells expressing a phosphorylation-deficient T486A mutant demonstrate decreased expression of c-Myb target genes Bcl-2 and Bcl-xL and accelerated apoptosis because of increased SUMOylation of the mutant protein. These results suggest that phosphorylation-dependent modulation of c-Myb SUMOylation may be important for proper response of cells to stress. In summary, we have identified a novel regulatory interplay between phosphorylation and SUMOylation of c-Myb that regulates its activity in stressed cells.

Entities:  

Keywords:  Apoptosis; Myb; Phosphorylation; Protein Degradation; Protein Stability; Stress; Sumoylation; Transcription; p38 MAPK

Mesh:

Substances:

Year:  2013        PMID: 24257756      PMCID: PMC3873556          DOI: 10.1074/jbc.M113.500264

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  54 in total

1.  Phosphorylation-dependent conformation and proteolytic stability of c-Myb.

Authors:  J Bies; S Feiková; J Markus; L Wolff
Journal:  Blood Cells Mol Dis       Date:  2001 Mar-Apr       Impact factor: 3.039

Review 2.  MYB function in normal and cancer cells.

Authors:  Robert G Ramsay; Thomas J Gonda
Journal:  Nat Rev Cancer       Date:  2008-07       Impact factor: 60.716

3.  Conditional c-myb knockout in adult hematopoietic stem cells leads to loss of self-renewal due to impaired proliferation and accelerated differentiation.

Authors:  Yen K Lieu; E Premkumar Reddy
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-02       Impact factor: 11.205

4.  Truncated c-Myb expression in the human leukemia cell line TK-6.

Authors:  A Tomita; T Watanabe; H Kosugi; H Ohashi; T Uchida; T Kinoshita; S Mizutani; T Hotta; T Murate; M Seto; H Saito
Journal:  Leukemia       Date:  1998-09       Impact factor: 11.528

5.  c-Myb is critical for B cell development and maintenance of follicular B cells.

Authors:  Matthew D Thomas; Christopher S Kremer; Kodi S Ravichandran; Klaus Rajewsky; Timothy P Bender
Journal:  Immunity       Date:  2005-09       Impact factor: 31.745

6.  v-Myb of E26 leukemia virus up-regulates bcl-2 and suppresses apoptosis in myeloid cells.

Authors:  J Frampton; T Ramqvist; T Graf
Journal:  Genes Dev       Date:  1996-11-01       Impact factor: 11.361

7.  The C-MYB locus is involved in chromosomal translocation and genomic duplications in human T-cell acute leukemia (T-ALL), the translocation defining a new T-ALL subtype in very young children.

Authors:  Emmanuelle Clappier; Wendy Cuccuini; Anna Kalota; Antoine Crinquette; Jean-Michel Cayuela; Willem A Dik; Anton W Langerak; Bertrand Montpellier; Bertrand Nadel; Pierre Walrafen; Olivier Delattre; Alain Aurias; Thierry Leblanc; Hervé Dombret; Alan M Gewirtz; André Baruchel; Francois Sigaux; Jean Soulier
Journal:  Blood       Date:  2007-04-23       Impact factor: 22.113

8.  Amplification of the c-myb oncogene in a case of human acute myelogenous leukemia.

Authors:  P G Pelicci; L Lanfrancone; M D Brathwaite; S R Wolman; R Dalla-Favera
Journal:  Science       Date:  1984-06-08       Impact factor: 47.728

9.  Transactivation properties of c-Myb are critically dependent on two SUMO-1 acceptor sites that are conjugated in a PIASy enhanced manner.

Authors:  Øyvind Dahle; Tor Ø Andersen; Oddmund Nordgård; Vilborg Matre; Giannino Del Sal; Odd S Gabrielsen
Journal:  Eur J Biochem       Date:  2003-03

10.  GSK3 regulates the expressions of human and mouse c-Myb via different mechanisms.

Authors:  Kyoko Kitagawa; Yojiro Kotake; Yoshihiro Hiramatsu; Ning Liu; Sayuri Suzuki; Satoki Nakamura; Akira Kikuchi; Masatoshi Kitagawa
Journal:  Cell Div       Date:  2010-11-21       Impact factor: 5.130

View more
  6 in total

1.  Transcription factor c-Myb: novel prognostic factor in osteosarcoma.

Authors:  Kamila Říhová; Monika Dúcka; Iva Staniczková Zambo; Ladislava Vymětalová; Martin Šrámek; Filip Trčka; Jan Verner; Stanislav Drápela; Radek Fedr; Tereza Suchánková; Barbora Pavlatovská; Eva Ondroušková; Irena Kubelková; Danica Zapletalová; Štěpán Tuček; Peter Múdry; Dagmar Adámková Krákorová; Lucia Knopfová; Jan Šmarda; Karel Souček; Lubor Borsig; Petr Beneš
Journal:  Clin Exp Metastasis       Date:  2022-01-07       Impact factor: 5.150

Review 2.  Situational awareness: regulation of the myb transcription factor in differentiation, the cell cycle and oncogenesis.

Authors:  Olivia L George; Scott A Ness
Journal:  Cancers (Basel)       Date:  2014-10-02       Impact factor: 6.639

3.  Bcr-TMP, a Novel Nanomolar-Active Compound That Exhibits Both MYB- and Microtubule-Inhibitory Activity.

Authors:  Maria V Yusenko; Abhiruchi Biyanee; Daria Frank; Leonhard H F Köhler; Mattias K Andersson; Cyrus Khandanpour; Rainer Schobert; Göran Stenman; Bernhard Biersack; Karl-Heinz Klempnauer
Journal:  Cancers (Basel)       Date:  2021-12-23       Impact factor: 6.639

4.  Src-Family Protein Kinase Inhibitors Suppress MYB Activity in a p300-Dependent Manner.

Authors:  Abhiruchi Biyanee; Maria V Yusenko; Karl-Heinz Klempnauer
Journal:  Cells       Date:  2022-03-30       Impact factor: 6.600

5.  Functional and structural analysis of non-synonymous single nucleotide polymorphisms (nsSNPs) in the MYB oncoproteins associated with human cancer.

Authors:  Shu Wen Lim; Kennet JunKai Tan; Osman Mohd Azuraidi; Maran Sathiya; Ee Chen Lim; Kok Song Lai; Wai-Sum Yap; Nik Abd Rahman Nik Mohd Afizan
Journal:  Sci Rep       Date:  2021-12-17       Impact factor: 4.379

Review 6.  The post-translational modification, SUMOylation, and cancer (Review).

Authors:  Zhi-Jian Han; Yan-Hu Feng; Bao-Hong Gu; Yu-Min Li; Hao Chen
Journal:  Int J Oncol       Date:  2018-02-22       Impact factor: 5.650

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.